Peptides for skin: do creams and serums work?

Do peptide creams reduce wrinkles?

A review of 19 studies included only two studies of products used on the skin. The other 17 tested products taken by mouth. Most positive combined results came from those oral products. No wrinkle result is proven for peptide creams as a group.

The studies used different ingredients, comparison products, measures, and study lengths. Some tested mixed formulas or treated each side of a person's face differently. A change in moisture, wrinkles, or people's ratings applies to the tested product and setting. The same result is not established for another serum.

Some products contain peptides with vitamin C, hyaluronic acid, or other active ingredients. A study of a mixture cannot show which ingredient caused a change. Cell studies also cannot prove a visible skin benefit in people.

What did the copper-peptide study find?

GHK-Cu is the short peptide glycyl-L-histidyl-L-lysine joined to copper. A cosmetic label may call it copper tripeptide-1. Lab work gives researchers a reason to study it, but it does not show a skin benefit in people. The clearest study in this review tested a GHK-Cu skin product after carbon-dioxide laser treatment.

Only 13 people finished the study. The study did not show a statistically significant difference between groups in how quickly redness improved. Computer measures and reviewers who did not know which treatment each person used also found no clear difference in wrinkles or overall skin quality. On a questionnaire, people using GHK-Cu gave higher ratings for overall skin quality.

The study measured skin healing after laser treatment, which differs from uninjured skin using an everyday serum. Its product and comparison do not represent every “copper peptide” product. The study gives no evidence that injected GHK-Cu improves skin or causes safe repair throughout the body. An injection claim needs its own study of that exact product and route.

What is known about side effects?

The review found few unwanted events in the included studies. Short studies of selected products cannot rule out rare harms or harms that take a long time to appear. A safety result for one cream does not apply to an untested formula or an injection.

A changing skin spot, a severe reaction, an infection, or symptoms after an unknown injection need medical care. A qualified clinician can assess the person and the exact product. This guide cannot diagnose a condition, verify an online product, or replace personal care.

What does a peptide ingredient on the label tell you?

Skin-care labels can list copper tripeptide-1, palmitoyl tripeptide-1, palmitoyl pentapeptide-4, acetyl hexapeptide-8, or other peptides. These are different ingredients, not versions of one standard “peptide complex.” Products can also differ in strength, stability, other ingredients, package, and how much reaches the skin.

FDA generally does not approve cosmetics before sale, and color additives are an important exception. The company that makes a cosmetic is responsible for safety and honest labels.

FDA also separates cosmetic and drug claims. Moisturizing skin or making lines look less clear through added moisture can be a cosmetic claim. A promise to remove wrinkles or increase collagen claims a change in the body's structure or function. Under U.S. law, that promise can make the product a drug.

“Cosmetic” is a legal category. That category does not prove that a formula works or has no risks.

Do collagen pills or powders help skin?

“Collagen peptides” usually means hydrolyzed collagen sold as a powder, capsule, drink, or another supplement. Hydrolyzed means broken into smaller pieces. The term covers a group of products, and the source, peptide size, serving contents, other ingredients, and quality controls can differ. Evidence for these supplements is separate from the evidence for a skin serum.

A 2025 review combined 23 randomized trials with 1,474 people. Across all trials combined, collagen supplements appeared to improve skin moisture, stretch, and wrinkles.

The result changed when the authors checked study quality and funding. Studies without funding from pharmaceutical companies did not show improvement. Higher-quality studies also did not show a clear benefit.

The positive skin-stretch result came from lower-quality studies. The authors concluded that current evidence did not support collagen supplements to prevent or treat skin aging.

The review shows how a headline built on all studies can make the evidence look stronger than it is. It does not prove that every collagen product has no effect, and it cannot show that two powders are equal.

FDA does not approve dietary supplements before sale. It also does not usually approve their claims or test each product before sale. A Supplement Facts panel shows that the item is sold as a supplement. A required claim disclaimer does not mean that FDA found the skin claim effective.

Do peptide injections improve skin?

An injection puts a product into the body by a different route. It needs different manufacturing controls and separate safety evidence.

FDA's compounding-risk page says GHK-Cu was nominated for injection, then withdrawn from review. FDA also says that human safety data are limited. It notes possible immune reactions linked to peptide clumps and unwanted peptide material.

These concerns apply to injection, so they do not show that every skin cream has the same risk. Cream results also cannot validate an injection.

A molecule name or lab certificate cannot show that a vial matches a study product. Neither proves the same sequence, chemical form, purity, sterility, strength, stability, or other ingredients. The sources reviewed here include no human outcome study showing that injected GHK-Cu improves skin or reverses aging. The reviewed evidence does not confirm a safe and effective injectable “skin peptide” group.

Melanotan II is a different molecule and product from afamelanotide. The Scenesse approval does not prove that melanotan II is safe, effective, well made, or protective against sunlight. FDA says compounded melanotan II may pose immune risks from peptide clumps or unwanted material.

FDA also notes case reports involving melanoma, posterior reversible encephalopathy syndrome, sympathomimetic toxidrome, and priapism. Posterior reversible encephalopathy syndrome is a serious brain condition. Sympathomimetic toxidrome is a toxic reaction that can overstimulate the body. Priapism is a long and painful erection.

Case reports are warning signals. They cannot show how common an event is or prove that a product caused it. This guide gives no injection, purchase, preparation, dosing, or product-selection instructions.

What is the approved skin medicine Scenesse used for?

Afamelanotide can affect skin color, but its approved product has a narrow medical use. FDA approved the Scenesse implant for adults with erythropoietic protoporphyria (EPP). EPP is a rare condition in which light can cause painful skin reactions. The implant can increase pain-free light exposure in adults with this condition and a history of those reactions.

The approval covers the exact implant, use, patient group, and professional care setting. Scenesse has no approval as a cosmetic tanning implant or anti-aging treatment.

The label calls for skin checks. It says that existing moles and freckles may darken. It also tells patients to keep using sun and light protection. The approved result does not show that darker skin makes ultraviolet exposure safe.

Evidence for Scenesse does not transfer to a cream, injected GHK-Cu, melanotan II, or an online product called “melanotan.” It does not transfer to a cream, injected GHK-Cu, melanotan II, or an online product called “melanotan.” A shared link to skin color does not make two molecules or products equal.

How can you check a skin-care promise?

Sales pages often combine an ingredient, a possible body effect, a study, and a product into one promise. Separate these parts before checking each one.

First, identify the product type: skin cosmetic, oral supplement, approved medicine, compounded drug, or research-labeled product. Write down the exact ingredient and finished product. A private “peptide blend” may not say what is in the product. A familiar brand term may name a mixture of several molecules.

Next, turn the promise into a result that can be measured. “Supports youthful skin” does not say whether the study checked wrinkles, moisture, stretch, redness, healing, skin color, or people's ratings.

Look for a controlled study in people of the same product, route, patient group, result, and time period. Check for other active ingredients. Check what the study used for comparison. Also check how many people finished, whether reviewers knew which product was used, and who paid for the study.

Finally, compare the sales claim with the actual result. A cell study about collagen does not prove fewer wrinkles. Higher ratings on a survey do not prove a change in skin structure.

A registered trial provides a result only once results are posted. “Dermatologist tested” does not say what was tested or whether it worked.

Weak evidence leaves the advertised benefit unconfirmed at that level. It also does not prove that a product cannot help.

• Name the exact ingredient, formulation, and route.
• Match the advertised benefit to the result that the study measured.
• Check the study size, length, comparison, reviewer knowledge, and funding.
• Do not transfer a result between topical, oral, implanted, and injected products.
• Treat regulatory status and evidence strength as separate questions.